Stay updated on Uproleselan with Chemotherapy for AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.

Latest updates to the Uproleselan with Chemotherapy for AML Clinical Trial page
- Check5 days agoChange DetectedThe study record now states that recruitment has ended with 'No longer looking for participants.' This indicates the trial is terminated and no new participants are being enrolled.SummaryDifference0.3%

- Check12 days agoChange DetectedThe page now shows a new revision tag, 'Revision: v3.5.5', replacing the previous 'Revision: v3.5.4'. This indicates an updated version of the page for QC and record-keeping without changes to the study details.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a small backend/template update. This change does not modify the substantive content or user-facing information on the page.SummaryDifference0.0%

- Check55 days agoChange DetectedClinicalTrials.gov’s page footer revision label was updated from v3.5.2 to v3.5.3, indicating a platform/site release rather than a change to the study record itself.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision: v3.5.0 is now shown, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Uproleselan with Chemotherapy for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.